SLT (CognivAiD™) Improves Memory and Cognition in Individuals With Mild Cognitive Impairment: Clinical Trial Results
09 nov. 2023 04h22 HE
|
Moleac Pte Ltd
Investigator-initiated clinical trial of SLT (CognivAiDTM) for mild cognitive impairment (MCI) reported significant improvement in key cognitive domains.
CAGR of 5.24% | Global Mild Cognitive Impairment Market Size To Grow USD 3.5 Billion By 2032
20 avr. 2023 08h50 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , April 20, 2023 (GLOBE NEWSWIRE) -- The Global Mild Cognitive Impairment (MCI) Market Size is To Grow from USD 2.1 Billion in 2022 to USD 3.5 Billion by 2032, at a Compound...
Cognitive Decline Market is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031)
25 avr. 2022 09h00 HE
|
Persistence Market Research
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to...
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
14 déc. 2020 08h00 HE
|
Posit Science
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...
New Study: Brain Exercises Drive Gains in Pre-Dementia Patients
16 mars 2020 08h00 HE
|
Posit Science
SAN FRANCISCO, March 16, 2020 (GLOBE NEWSWIRE) -- A newly published imaging study in NeuroImage from researchers at the University of Rochester has shown that brain training drove improvements in...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
DiamiR Provides Update on Its Patent Portfolio, Launches New Website
26 sept. 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - September 26, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, reported today that...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18 mars 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
DiamiR Announces Research Collaboration With Johnson & Johnson Innovation
11 janv. 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - January 11, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that it has entered into a research...